
Pharmaceutical Executive
Three key questions dominate the agency’s Breakthrough Therapy Designation program since its 2012 launch.

Pharmaceutical Executive
Three key questions dominate the agency’s Breakthrough Therapy Designation program since its 2012 launch.

Pharmaceutical Executive
The US drug regulatory system fails to address the country’s most urgent medical needs with the resources appropriate for the task. But change is possible.

February 1st 2015

September 8th 2015